MUMBAI, India, Aug. 10 -- Intellectual Property India has published a patent application (202617077113 A) filed by Alpha Beta Holdings, LLC on June 22, 2026, for Compositions And Methods For Treating Cancer And Fibrotic Disorders.
Inventors include Mccormack, Stephen; Cheresh, David; Weis, Sara; Wu, Cheng; and Von Schalscha, Tami.
The application for the patent was published on July 31, 2026, under issue no. 31/2026.
Abstract: The present invention relates to antibodies (e.g., bispecific antibodies, or antigen-binding fragments thereof), and compositions comprising the same. The invention further relates to polynucleotides encoding the antibodies, or antigen-binding fragments thereof, and vectors and host cells comprising the same. The invention further relates to methods of using the antibodies, or antigen-binding fragments thereof, to prevent binding of the cell to fibronectin and methods of treating cancers and fibrotic disorders. The invention further relates to the simultaneous inhibition of ligand binding to a specific combination of integrin receptors. The invention further relates to the inhibition of expression of a predetermined combination of integrin receptor subunits through nucleic acid action on the mRNAs.
Disclaimer: Curated by HT Syndication.
